Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

HKG/2617 stock hub

HKG/2617 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

HKG/2617is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
22.3B
Hong Kong Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
HKG/2617
In the news

Latest news · HKG/2617

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 11.7P50 18.9P75 41.4
Trailing P/En/a
P25 10.7P50 17.9P75 38.5
ROE-62.9
P25 -14.7P50 2P75 9.4
ROIC-39.8
P25 -10.4P50 1.9P75 10.5
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All HKG/2617 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
135
Groups with data
10
Currency
CNY
Showing 135 of 135 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

17
MetricValue
Country
China
Country code
HK
Employees
123
Enterprise value
HKD 21.8B
Exchange
Hong Kong Stock Exchange
Financial currency
CNY
First seen
2026-05-10
Industry
Biotechnology
Isin
CNE100006T02
Last refreshed
2026-05-10
Market cap
HKD 22.3B
Price
HKD 55.2
Price currency
HKD
Sector
Healthcare
Sic
2836
Symbol
hkg/2617
Website
https://www.transthera.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

5
MetricValue
Earnings Yield
-1.48%
EV Earnings
-66.08x
EV/FCF
-77.09x
FCF yield
-1.27%
P/B ratio
48.14x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

6
MetricValue
Net Income
HKD -329.4M
Profit Per Employee
HKD -2.7M
ROA
-32.06
ROCE
-72.42
ROE
-62.88
ROIC
-39.78

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

18
MetricValue
Assets
HKD 607.5M
Cash
HKD 544.6M
Current Assets
HKD 576.8M
Current Liabilities
HKD 149.2M
Debt
HKD 1.8M
Debt Equity
HKD 0
Debt FCF
HKD -0.01
Equity
HKD 463.3M
Interest Coverage
-2,492.1
Liabilities
HKD 144.1M
Long Term Assets
HKD 30.7M
Long Term Liabilities
HKD -5M
Net Cash
HKD 542.8M
Net Cash By Market Cap
HKD 2.43
Net Cash Growth
-14.37%
Net Debt Equity
HKD -1.17
Tangible Book Value
HKD 462.9M
Tangible Book Value Per Share
HKD 1.17

Liquidity

Current-asset coverage and working-capital efficiency metrics.

4
MetricValue
Current ratio
3.87
Net Working Capital
HKD -129.6M
Quick ratio
3.8
Working Capital
HKD 413.2M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-2.11%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

32
MetricValue
200-day SMA
107.6
50-day SMA
66.76
50-day SMA vs 200-day SMA
50under200
All Time High
679.5
All Time High Change
-91.88%
All Time High Date
2025-09-16
All Time Low
20.2
All Time Low Change
173.27%
All Time Low Date
2025-06-23
ATR
4.48
Beta1y
0.35
Ch YTD
-51.96
High
58.8
High52
679.5
High52 Date
2025-09-16
High52ch
-91.88%
Low
47.4
Low52
20.2
Low52 Date
2025-06-23
Low52ch
173.27%
Ma50ch
-17.31%
Price vs 200-day SMA
-48.69%
RSI
40.99
RSI Monthly
0
RSI Weekly
38.09
Sharpe ratio
1.29x
Sortino ratio
3.16
Total Return
-2.11%
Tr YTD
-51.96
Tr1m
-21.26%
Tr1w
3.57%
Tr3m
-21.81%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

1
MetricValue
Operating Income
HKD -335.6M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
125,346,249%
Net Borrowing
-3,085,037.4
Shares Insiders
11.84%
Shares Institutions
28.32%
Shares Out
404,082,633
Shares Qo Q
3.9%
Shares Yo Y
2.11%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

44
MetricValue
Adjusted FCF
HKD -299M
Average Volume
1,563,016x
Bv Per Share
1.17
CAPEX
HKD -182,501
Ch1m
-21.26
Ch1w
3.57
Ch3m
-21.81
Ch6m
-75.02
Change
15.82%
Change From Open
15.87
Close
47.66
Days Gap
-0.04
Depreciation Amortization
2,265,124.5
Dollar Volume
593,036,342.4
Earnings Date
2026-05-22
EBIT
HKD -335.6M
EBITDA
HKD -333.4M
EPS
HKD -0.85
F Score
1
FCF
HKD -282.3M
FCF EV Yield
-1.3x
FCF Per Share
HKD -0.7
Financing CF
188,059,368
Fiscal Year End
December
Founded
2,014
Investing CF
-75,668,871
Is Primary Listing
1
Last Earnings Date
2026-03-31
Last Report Date
2025-12-31
Ma150
118.4
Ma150ch
-53.39%
Ma20
60.23
Ma20ch
-8.35%
Net CF
-171,481,834
Next Earnings Date
2026-05-22
Open
47.64
Position In Range
68.42
Ppne
27,663,999.2
Price Date
2026-05-08
Ptbv Ratio
48.19
Relative Volume
7.03x
Share Based Comp
16,756,697
Tr6m
-75.02%
Volume
10,743,412
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does HKG/2617 pay a dividend?

Capital-return profile for this ticker.

Ownership

Who owns HKG/2617?

Insider, institutional, and short-interest positioning.

Institutional ownership
+28.3%
Share of float held by funds and institutions
Insider ownership
+11.8%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+2.1%
Negative means the company is buying back shares.
Technical

HKG/2617 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
41.0
Neutral momentum band
Price vs 200-day MA
-48.7%
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
1.29
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About HKG/2617

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hkg/2617 stock rating?

hkg/2617 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hkg/2617 analysis?

The full report lives at /stocks/hkg/2617/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hkg/2617?

The latest report frames hkg/2617 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hkg/2617 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

hkg/2617 stock profile: metrics, valuation and analysis | StockMarketAgent.AI